S100A2 and pancreatic neoplasm: For instance, previous studies reported that S100A2 and S100A10 were the negative biomarker for pancreatic cancer (PC), while S100A4 was profoundly involved in the chemoresistance and survival in are negative prognostic biomarkers in PC cells [12–14].